Administration of Lipids Through Peripheral IV in Severely Malnourished Hospitalized Patients
Peripheral administration of lipids is an appropriate and safe approach for short-term nutritional support in severely malnourished hospitalized patients, and can be considered standard of care when the expected duration of parenteral nutrition is less than 10-14 days. 1
Rationale for Peripheral Lipid Administration
- Lipid emulsions can be safely administered through peripheral veins and provide a concentrated energy source while helping prevent essential fatty acid deficiency in malnourished patients 2
- An increase in energy intake can be achieved in the short-term by administration of lipids using peripheral venous access, making it a valuable option for severely malnourished patients 1
- Peripheral parenteral nutrition (PPN) allows early infusion of nutritional substrates during acute illness without the need to insert a central venous catheter, reducing procedural risks 1
Clinical Parameters for Peripheral Lipid Administration
- Peripheral PN can cover nutrition needs in malnourished patients with regimens incorporating up to 1700 kcal, 60 g of amino acids, 60-80 g of lipids, and 150-180 g of carbohydrates per day in a typical volume of 2400 ml 1
- The osmolarity of peripheral parenteral nutrition should not exceed 850-900 mOsm/l to minimize phlebitis risk 1
- Using very fine bore silicon or polyurethane catheters and infusion pump-controlled continuous administration, peripheral nutrition can be tolerated up to 1000 mOsm/l 1
- The "osmolarity rate" (number of milliosmols infused per hour) correlates well with phlebitis risk and should be limited when using peripheral administration 3
Duration Considerations
- The peripheral route should be limited to those with an anticipated duration of feeding of no more than 10-14 days 1
- If the expected PN period is between 4-7 days, nutrition can be hypocaloric with 2 g carbohydrate and 1 g amino acids/kg body weight administered via a peripheral catheter 1
- For PN expected to last more than 7-10 days, a central venous catheter should be inserted 1
Monitoring and Safety Considerations
- Close monitoring of plasma triglycerides is essential in malnourished patients, with adjustment of lipid infusion rate if necessary 2
- Triglyceride values should be kept below 12 mmol/L (approximately 1,000 mg/dL) to prevent fat overload syndrome 2
- Phosphate, potassium, and magnesium levels should be normalized before starting PN, especially in malnourished patients, to prevent refeeding syndrome 4
- In patients with alcoholic liver disease, vitamin B1 (thiamine) must be administered prior to starting glucose infusion to reduce the risk of Wernicke's encephalopathy 4
Lipid Emulsion Selection
- Use lipid emulsions with a content of n-6 unsaturated fatty acids lower than in traditional pure soybean oil emulsions 1
- Composite lipid emulsions containing fish oil may have less pro-inflammatory effects and more antioxidant effects than pure soybean oil emulsions, potentially benefiting critically ill malnourished patients 2, 5
- For patients requiring long-term parenteral nutrition, consider using mixed LCT/MCT (long-chain/medium-chain triglyceride) formulations 2
Practical Implementation
- For administration of parenteral nutrition, an all-in-one (three-chamber bag or pharmacy prepared) should be preferred instead of a multibottle system 1
- Standardized operating procedures (SOP) for nutritional support are recommended to secure effective nutritional support therapy 1
- The use of peripherally inserted catheters for peripheral (midline catheters) PN might help in controlling the incidence of infectious or thrombotic complications 1
Special Considerations for Severely Malnourished Patients
- Start PN immediately in moderately or severely malnourished patients who cannot be fed sufficiently either orally or enterally 1
- In malnourished patients, physical activity is a necessary condition for significant muscle gain when receiving parenteral nutrition 1
- Regular blood glucose monitoring is essential to avoid PN-related hyperglycemia, with glucose infusion rates reduced to 2-3 g/kg/d in case of hyperglycemia 1, 4